Schizophrenia Completed Phase 3 Trials for Haloperidol (DB00502)

Also known as: Dementia Praecox / Schizophrenic Disorders / Schizophrenic Disorder / Schizophrenia NOS / Schizophrenia, unspecified / Unspecified schizophrenia / Unspecified schizophrenia, unspecified state

IndicationStatusPhase
DBCOND0018504 (Schizophrenia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02431702A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or SchizophreniformTreatment
NCT00156104Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED)Treatment
NCT00156065Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785)Treatment
NCT00485901Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With SchizophreniaTreatment
NCT00723606A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With AgitationTreatment
NCT00797277Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in SchizophreniaTreatment